Children’s ZYRTEC® Clinical Data
Consistent improvement of symptoms throughout the 2-week treatment period
Reduction from baseline in total symptom severity complex (TSSC)*†1
- 37% and 40% reduction observed after 2 weeks of treatment in the 10-mg group
- 63% and 40% reduction observed after 2 weeks of treatment in the 5-mg group
All studies are multicenter, randomized, placebo-controlled, double-blind in children ages 2 to 11 years with previous diagnosis of SAR, and adequate minimum duration (2 weeks).
*TSSC = Total Symptom Severity Complex.
†Adjusted mean change relative to baseline.
Reference: 1. Urdaneta ER, Przygoda PA, Lin CL, et al. Regular use of cetirizine demonstrates consistent relief from symptoms of seasonal allergic rhinitis in children. J Allergy Clin Immunol. 2011;127(suppl 2):AB 202.
Learn more about Children's ZYRTEC®
View Children's ZYRTEC® tolerability profile
Help educate children and caregivers about allergies with an educational brochure and storybook.